We are live on
!
Find out more
Immunic
IMUX
IMUX
53 hedge funds and large institutions have $44.8M invested in Immunic in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
525% more call options, than puts
Call options by funds: $100K | Put options by funds: $16K
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
28% more capital invested
Capital invested by funds: $35M → $44.8M (+$9.89M)
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
0% more ownership
Funds ownership: 0.07% → 0.07% (+0%)
4% less funds holding
Funds holding: 55 → 53 (-2)
Holders
53
Holders Change
-2
Holders Change %
-3.64%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
15
Reduced
14
Closed
5
Calls
$100K
Puts
$16K
Net Calls
+$84K
Net Calls Change
-$35K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.86M |
| 2 |
BlackRock
New York
|
+$6.22M |
| 3 |
AG
Artal Group
Luxembourg
|
+$4.01M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$1.02M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$915K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$458K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$270K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$210K |
| 4 |
Morgan Stanley
New York
|
-$172K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$66K |
